MedPath

Comparison between adrenaline vs noradrenaline in children with cancer presenting with shock

Phase 3
Conditions
Health Condition 1: R031- Nonspecific low blood-pressure reading
Registration Number
CTRI/2022/09/045180
Lead Sponsor
Apollo Hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hematoncology patients aged 1 month to 17 years with early shock, defined as children with unresolved shock/hypoperfusion after the initial 10- 20ml/kg fluid bolus.

Exclusion Criteria

1.Children with fulminant myocarditis

2.Children with established, untreated heart disease

3.Parents not willing to participate in the study

4.Caregiver/Physician unwilling for patient to be enrolled

5.Post-arrest shock

6.Moribund patients in whom anticipated survival < 24 hrs (since many are in recalcitrant downward spiral of overall condition where the impact of one or other vasoactive may be difficult to assess).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pilot study to assess feasibility for randomized control trial enrolment, adherence to trial protocol and follow up with respect to resolution of shock in hematoncology patients aged 1 month to 17 years with early undifferentiated shock.Timepoint: 1.Fluid requirement in 0-6 hours and 6-24 hours <br/ ><br>2.Vasoactive-inotrope score at 6 hours <br/ ><br>3.Days alive and free of organ support (ventilator support, Renal replacement therapy) up to 28-days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To determine the choice of first vasoactive agent between epinephrine and norepinephrine in pediatric hematoncology patients with undifferentiated shockTimepoint: 1.Fluid requirement in 0-6 hours and 6-24 hours <br/ ><br>2.Vasoactive-inotrope score at 6 hours <br/ ><br>3.Days alive and free of organ support (ventilator support, Renal replacement therapy) up to 28-days <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath